TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in statin-treated patients with familial hypercholesterolemia
- 27 April 2005
- journal article
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 13 (7) , 877-882
- https://doi.org/10.1038/sj.ejhg.5201426
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Relationship between cholesteryl ester transfer protein and LDL heterogeneity in familial hypercholesterolemiaJournal of Lipid Research, 2004
- The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemiaPublished by Elsevier ,2004
- Cardiovascular disease and mortality in statin-treated patients with familial hypercholesterolemiaAtherosclerosis, 2004
- Association of Cholesteryl Ester Transfer Protein– Taq IB Polymorphism With Variations in Lipoprotein Subclasses and Coronary Heart Disease RiskArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical managementAtherosclerosis, 1999
- Heterogeneity at theCETPGene LocusArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkersAtherosclerosis, 1994
- Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqI B RFLP in the CETP gene and smoking and obesity.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASEThe Lancet, 1975
- Coronary Artery Disease in 116 Kindred with Familial Type II HyperlipoproteinemiaCirculation, 1974